SAI
VIR icon

Savvy Advisors Inc’s Vir Biotechnology VIR Stock Holding History

Savvy Advisors Inc’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
+1,040,665
New +$9.9M 0.23% 85

Other funds holding VIR

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Savvy Advisors Inc's VIR Position: Q2 2026 in Review

Savvy Advisors Inc opened a new position in Vir Biotechnology (VIR) in Q2 2026: 1,040,665 shares worth $10.6M. The stake represents 0.23% of the portfolio and ranks #85 among its holdings.

57 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Savvy Advisors Inc held 1,040,665 shares of Vir Biotechnology worth $10.6M as of Q2 2026.
  • Vir Biotechnology was a new Savvy Advisors Inc position in Q2 2026.
  • Vir Biotechnology made up 0.23% of Savvy Advisors Inc's portfolio in Q2 2026, its #85 holding.
  • 57 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.